Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance
- Genome Res., Published in Advance August 29, 2019, 29: 1442-1452 | doi: 10.1101/gr.246900.118